Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England

10 Jul 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to CRISPR and Genetic Engineering
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32651552
DOI: 10.1038/s41431-020-0692-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of EnglandPMID 32651552Read ↗

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinicsSemantic proximity Read ↗

Oncologist-led BRCA ‘mainstreaming’ in the ovarian cancer clinic: A study of 255 patients and its impact on their managementSemantic proximity Read ↗

Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?Semantic proximity Read ↗

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST StudySemantic proximity Read ↗

Mainstreamed genetic testing in ovarian cancer: patient experience of the testing processSemantic proximity Read ↗

Examining the uptake of predictive BRCA testing in the UK; findings and implicationsSemantic proximity Read ↗

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.Semantic proximity Read ↗

Mainstreamed genetic testing for women with ovarian cancer: first-year experience.Semantic proximity Read ↗

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: Evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathwaySemantic proximity Read ↗

An Australian mainstream genetic testing program: Clinicians views about current and future practicesSemantic proximity Read ↗

Mainstreaming cancer genetics: feasibility of an advanced nurse practitioner-led service diagnosing Lynch syndrome from colorectal cancer in IrelandSemantic proximity Read ↗

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.